A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
New Understanding of Leukocyte Migration
A recent Northwestern Medicine study has revealed previously unknown details about calcium signaling that can contribute to inflammation.
Earlier Treatment May Reduce Cardiovascular Disease
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.